Host risk factors for the development of multiple non-melanoma skin cancers

Por Qureshi, A.A., Wei-Passanese, E.X., Li, T., Han, J.
Publicado em 2012

Burden of chronic urticaria relative to psoriasis in five European countries

Por Balp, M.M., Khalil, S., Tian, H., Gabriel, S., Vietri, J., Zuberbier, T.
Publicado no J Eur Acad Dermatol Venereol (2017)

Antiviral gene expression in psoriasis

Por Raposo, R.A., Gupta, R., Abdel-Mohsen, M., Dimon, M., Debbaneh, M., Jiang, W., York, V.A., Leadabrand, K.S., Brown, G., Malakouti, M., Arron, S., Kuebler, P.J., Wu, J.J., Pillai, S.K., Nixon, D.F., Liao, W.
Publicado no J Eur Acad Dermatol Venereol (2015)

Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis...

Por Queille‐Roussel, C., Bang, B., Clonier, F., Lacour, J.‐P.
Publicado no J Eur Acad Dermatol Venereol (2016)

Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study

Por Bewley, A, Burrage, D M, Ersser, S J, Hansen, M, Ward, C
Publicado no J Eur Acad Dermatol Venereol (2014)

Phase 3, open‐label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector...

Por Callis Duffin, K., Bagel, J., Bukhalo, M., Mercado Clement, I.J., Choi, S.L., Zhao, F., Gill, A., Pangallo, B., Shuler, C., Mallbris, L., Jackson, K.
Publicado no J Eur Acad Dermatol Venereol (2016)

Laser and Light-based Treatment of Keloids – A Review

Por Mamalis, A.D., Lev-Tov, H., Nguyen, D.H., Jagdeo, J.R.
Publicado no J Eur Acad Dermatol Venereol (2013)

Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence...

Por Maurer, M., Sofen, H., Ortiz, B., Kianifard, F., Gabriel, S., Bernstein, J.A.
Publicado no J Eur Acad Dermatol Venereol (2017)

Prevalence of rosacea in the general population of Germany and Russia – The RISE study

Por Tan, J., Schöfer, H., Araviiskaia, E., Audibert, F., Kerrouche, N., Berg, M.
Publicado no J Eur Acad Dermatol Venereol (2016)

Phase I randomized study of KHK4083, an anti‐OX40 monoclonal antibody, in patients with mild to moderate plaque psoriasis

Por Papp, K.A., Gooderham, M.J., Girard, G., Raman, M., Strout, V.
Publicado no J Eur Acad Dermatol Venereol (2017)

DNA methylation of the filaggrin gene adds to the risk of eczema associated with loss-of-function variants

Por Ziyab, A. H., Karmaus, W., Holloway, J. W., Zhang, H., Ewart, S., Arshad, S. H.
Publicado em 2012

Promoting patient‐centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience

Por Betteridge, N., Boehncke, W.‐H., Bundy, C., Gossec, L., Gratacós, J., Augustin, M.
Publicado no J Eur Acad Dermatol Venereol (2015)

Protease-modulating polyacrylate-based hydrogel stimulates wound bed preparation in venous leg ulcers – a randomized controlled trial

Por Humbert, P, Faivre, B, Véran, Y, Debure, C, Truchetet, F, Bécherel, P-A, Plantin, P, Kerihuel, J-C, Eming, SA, Dissemond, J, Weyandt, G, Kaspar, D, Smola, H, Zöllner, P
Publicado no J Eur Acad Dermatol Venereol (2014)

Topical ionic contra‐viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts

Por van der Kolk, T., Dillingh, M.R., Rijneveld, R., Klaassen, E.S., de Koning, M.N.C., Kouwenhoven, S.T.P., Genders, R.E., Bouwes Bavinck, J. N., Feiss, G., Rissmann, R., Burggraaf, J.
Publicado no J Eur Acad Dermatol Venereol (2017)

Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology

Por Dreno, B, Bensadoun, RJ, Humbert, P, Krutmann, J, Luger, T, Triller, R, Rougier, A, Seité, S
Publicado em 2013

LONG – TERM SAFETY OF REPLICATION-DEFECTIVE SMALLPOX VACCINE (MVA-BN) IN ATOPIC ECZEMA AND ALLERGIC RHINITIS

Por Darsow, U, Sbornik, M, Rombold, S, Katzer, K, von Sonnenburg, F, Behrendt, H, Ring, J
Publicado no J Eur Acad Dermatol Venereol (2016)

Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient‐reported outcomes from a Phase 3 study

Por Valenzuela, F., Paul, C., Mallbris, L., Tan, H., Papacharalambous, J., Valdez, H., Mamolo, C.
Publicado no J Eur Acad Dermatol Venereol (2016)

Early outcome of a 31‐gene expression profile test in 86 AJCC stage IB‐II melanoma patients. A prospective multicentre cohort study

Por Podlipnik, S., Carrera, C., Boada, A., Richarz, N.A., López‐Estebaranz, J.L., Pinedo‐Moraleda, F., Elosua‐González, M., Martín‐González, M.M., Carrillo‐Gijón, R., Redondo, P., Moreno, E., Malvehy, J., Puig, S.
Publicado no J Eur Acad Dermatol Venereol (2019)

Betamethasone valerate dressing is non-inferior to calcipotriol–betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: res...

Por Ortonne, J-P, Esposito, M, Chimenti, S, Kapińska-Mrowiecka, M, Grodzińska, A, Naldi, L, Frangione, V
Publicado no J Eur Acad Dermatol Venereol (2014)

Secukinumab Treatment of Plaque Psoriasis Shows Early Improvement in DLQI Response — Results of a Phase 2 Regimen-Finding Trial

Por Augustin, M., Abeysinghe, S., Mallya, U., Qureshi, A., Roskell, N., McBride, D., Papavassillis, C., Gelfand, J.
Publicado no J Eur Acad Dermatol Venereol (2015)